UnitedHealth Group (NYSE: UNH) pointed out confidence in its merger with Amedisys (Nasdaq: Amed) in a document prepared for shareholders.
An earlier draft of the document, marked as “privileged and confidential”, was sent by error to a statistics reporter, according to the publication. After Stat informed UnitedHealth of his intentions to inform about the document, UnitedHealth published a slightly altered version of the document on its website, according to Stat.
In both versions of the 18 -page document, UnitedHealth its merger proposes with Amedisys, which has been concerned about antimonopoly Conerns and an investigation carried out by the Department of Justice (DOJ).
“We remain optimistic that we will complete our proposed fusion with Amedisys,” said the document. “Amedisys’ commitment to innovation of quality and care within the home, and the culture of the first patient of its people combined with the experience of care based on the deep value of Optum, can promote a significant improvement in the health results and the costs of gratche of experts.
Companies have tried to get rid of the assets twice in an effort to quell anti -disease concerns.
In June 2024, UnitedHealth and Amedisys announced plans to disin more than 100 health locations at home and hospice for Vitalcaring. According to reports, the agreement was arrested in January. In May, companies announced a planned divestment to the Pennant Group (Nasdaq: PNTG) and Brightspring Health Services (Nasdaq: BTSG). Less than two weeks later, the DOJ, according to reports, rejected divestment.
UnitedHealth also addressed “potential investigations” by the DOJ in the shareholders meeting document.
“We do not comment or speculate on the intentions of the DOJ,” said the document.
In addition, the company commented on the coverage of Wall Street Journal (WSJ) that reported that the company was under investigation by the DOJ for Medicare Advantage fraud. The company said it would not comment on “accusations and speculations.”
“If he pushed on WSJ’s stories: the Wall Street Journal used a defective analysis and inaccurate data for
Painting an incomplete image of a program that provides better health results and more
Ashequible medical care for millions of older people, “it reads in the leaked document.” In comparison with Medicare de Tarifa per service, Medicare Advantage costs less and is more equitable, with broader coverage and benefits, such as consumer satisfaction of 95% broader. “
The company said that “firmly supports the integrity of our MA program”, and that it has urged CMS to perform more frequent audits of the ma plans.
